Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19

The aim: to highlight the importance of considering hemophagocytic lymphohistiocytosis in patients with jaundice of unclear origin and systemic inflammatory manifestations after coronavirus infection.Key points. A 64-y.o. patient was admitted to the hospital with jaundice, pruritus, fatigue, weight...

Full description

Saved in:
Bibliographic Details
Main Authors: V. R. Grechishnikova, P. E. Tkachenko, M. S. Zharkova, T. P. Nekrasova, V. T. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2022-09-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/727
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860101512953856
author V. R. Grechishnikova
P. E. Tkachenko
M. S. Zharkova
T. P. Nekrasova
V. T. Ivashkin
author_facet V. R. Grechishnikova
P. E. Tkachenko
M. S. Zharkova
T. P. Nekrasova
V. T. Ivashkin
author_sort V. R. Grechishnikova
collection DOAJ
description The aim: to highlight the importance of considering hemophagocytic lymphohistiocytosis in patients with jaundice of unclear origin and systemic inflammatory manifestations after coronavirus infection.Key points. A 64-y.o. patient was admitted to the hospital with jaundice, pruritus, fatigue, weight loss. The complaints occurred 2 weeks after discharge from the hospital for treatment of patients with coronavirus infection. Laboratory tests revealed signs of hepatic insufficiency, markers of cholestasis and inflammation persisted in time. Upon instrumental examination no signs of hepatosplenomegaly, biliary tree changes, intra- and extrahepatic obstruction were found. S. aureus was identified in blood cultures, CT scan of the facial skull bones showcased the focus of infection in the area of the roots of teeth 2.4 and 2.5. Therefore, antibiotics were prescribed. Subsequently, the patient's condition was complicated by the development of two episodes of acute respiratory distress syndrome, which occurred during the withdrawal of glucocorticosteroid therapy. Liver biopsy was performed, morphological study revealed signs of “vanishing bile duct” syndrome, excessive activation of macrophages and hemosiderosis of sinusoidal cells. Identified lesions can be found in hemophagocytic lymphohistiocytosis (HLH), a life-threatening complication of coronavirus infection. Glucocorticosteroids therapy, transfusions of human immunoglobulin, albumin, and parenteral nutrition have led to patient's condition improvement.Conclusion. COVID-19 provokes the development of secondary HLH 10 times more often than other respiratory viral infections. The possibility of hemophagocytic syndrome development should be considered, including cases of overlap syndrome with sepsis, in patients with unresolved jaundice, hyperferritinemia after coronavirus infection. Routinely used scales and criteria for diagnosis of HLH (H-score, HLH 2004) in such cases lacks sensitivity, therefore, careful analysis of clinical picture and exclusion of other causes of jaundice are required.
format Article
id doaj-art-0a80ec681ebd44be8be57c36d6ea369b
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2022-09-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-0a80ec681ebd44be8be57c36d6ea369b2025-02-10T16:14:37ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732022-09-01323576710.22416/1382-4376-2022-32-3-57-67473Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19V. R. Grechishnikova0P. E. Tkachenko1M. S. Zharkova2T. P. Nekrasova3V. T. Ivashkin4Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)The aim: to highlight the importance of considering hemophagocytic lymphohistiocytosis in patients with jaundice of unclear origin and systemic inflammatory manifestations after coronavirus infection.Key points. A 64-y.o. patient was admitted to the hospital with jaundice, pruritus, fatigue, weight loss. The complaints occurred 2 weeks after discharge from the hospital for treatment of patients with coronavirus infection. Laboratory tests revealed signs of hepatic insufficiency, markers of cholestasis and inflammation persisted in time. Upon instrumental examination no signs of hepatosplenomegaly, biliary tree changes, intra- and extrahepatic obstruction were found. S. aureus was identified in blood cultures, CT scan of the facial skull bones showcased the focus of infection in the area of the roots of teeth 2.4 and 2.5. Therefore, antibiotics were prescribed. Subsequently, the patient's condition was complicated by the development of two episodes of acute respiratory distress syndrome, which occurred during the withdrawal of glucocorticosteroid therapy. Liver biopsy was performed, morphological study revealed signs of “vanishing bile duct” syndrome, excessive activation of macrophages and hemosiderosis of sinusoidal cells. Identified lesions can be found in hemophagocytic lymphohistiocytosis (HLH), a life-threatening complication of coronavirus infection. Glucocorticosteroids therapy, transfusions of human immunoglobulin, albumin, and parenteral nutrition have led to patient's condition improvement.Conclusion. COVID-19 provokes the development of secondary HLH 10 times more often than other respiratory viral infections. The possibility of hemophagocytic syndrome development should be considered, including cases of overlap syndrome with sepsis, in patients with unresolved jaundice, hyperferritinemia after coronavirus infection. Routinely used scales and criteria for diagnosis of HLH (H-score, HLH 2004) in such cases lacks sensitivity, therefore, careful analysis of clinical picture and exclusion of other causes of jaundice are required.https://www.gastro-j.ru/jour/article/view/727covid-19sars-cov-2 infectionhemophagocytic lymphohistiocytosishlhh-scorehlh 2004“vanishing bile duct” syndrome
spellingShingle V. R. Grechishnikova
P. E. Tkachenko
M. S. Zharkova
T. P. Nekrasova
V. T. Ivashkin
Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
covid-19
sars-cov-2 infection
hemophagocytic lymphohistiocytosis
hlh
h-score
hlh 2004
“vanishing bile duct” syndrome
title Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
title_full Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
title_fullStr Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
title_full_unstemmed Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
title_short Patient with Jaundice, Dyspnea and Hyperferritinemia after COVID-19
title_sort patient with jaundice dyspnea and hyperferritinemia after covid 19
topic covid-19
sars-cov-2 infection
hemophagocytic lymphohistiocytosis
hlh
h-score
hlh 2004
“vanishing bile duct” syndrome
url https://www.gastro-j.ru/jour/article/view/727
work_keys_str_mv AT vrgrechishnikova patientwithjaundicedyspneaandhyperferritinemiaaftercovid19
AT petkachenko patientwithjaundicedyspneaandhyperferritinemiaaftercovid19
AT mszharkova patientwithjaundicedyspneaandhyperferritinemiaaftercovid19
AT tpnekrasova patientwithjaundicedyspneaandhyperferritinemiaaftercovid19
AT vtivashkin patientwithjaundicedyspneaandhyperferritinemiaaftercovid19